Cargando…

COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, soci...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Joshua, Bodinier, Barbara, Whitaker, Matthew, Delpierre, Cyrille, Vermeulen, Roel, Tzoulaki, Ioanna, Elliott, Paul, Chadeau-Hyam, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882869/
https://www.ncbi.nlm.nih.gov/pubmed/33587202
http://dx.doi.org/10.1007/s10654-021-00722-y
_version_ 1783651136819953664
author Elliott, Joshua
Bodinier, Barbara
Whitaker, Matthew
Delpierre, Cyrille
Vermeulen, Roel
Tzoulaki, Ioanna
Elliott, Paul
Chadeau-Hyam, Marc
author_facet Elliott, Joshua
Bodinier, Barbara
Whitaker, Matthew
Delpierre, Cyrille
Vermeulen, Roel
Tzoulaki, Ioanna
Elliott, Paul
Chadeau-Hyam, Marc
author_sort Elliott, Joshua
collection PubMed
description Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10(–17)), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10(–6)) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10(–7)) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10654-021-00722-y.
format Online
Article
Text
id pubmed-7882869
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-78828692021-02-16 COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors Elliott, Joshua Bodinier, Barbara Whitaker, Matthew Delpierre, Cyrille Vermeulen, Roel Tzoulaki, Ioanna Elliott, Paul Chadeau-Hyam, Marc Eur J Epidemiol Covid-19 Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18–3.49] per S.D. [8.1 years], p = 2.6 × 10(–17)), male sex (OR = 1.47 [1.26–1.73], p = 1.3 × 10(–6)) and Black versus White ethnicity (OR = 1.21 [1.12–1.29], p = 3.0 × 10(–7)) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin–angiotensin–aldosterone system inhibitors may be explained by the aforementioned factors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10654-021-00722-y. Springer Netherlands 2021-02-15 2021 /pmc/articles/PMC7882869/ /pubmed/33587202 http://dx.doi.org/10.1007/s10654-021-00722-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Covid-19
Elliott, Joshua
Bodinier, Barbara
Whitaker, Matthew
Delpierre, Cyrille
Vermeulen, Roel
Tzoulaki, Ioanna
Elliott, Paul
Chadeau-Hyam, Marc
COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title_full COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title_fullStr COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title_full_unstemmed COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title_short COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
title_sort covid-19 mortality in the uk biobank cohort: revisiting and evaluating risk factors
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882869/
https://www.ncbi.nlm.nih.gov/pubmed/33587202
http://dx.doi.org/10.1007/s10654-021-00722-y
work_keys_str_mv AT elliottjoshua covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT bodinierbarbara covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT whitakermatthew covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT delpierrecyrille covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT vermeulenroel covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT tzoulakiioanna covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT elliottpaul covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors
AT chadeauhyammarc covid19mortalityintheukbiobankcohortrevisitingandevaluatingriskfactors